A study based on an extensive review of cases and forensic analysis of explanted IOLs provided reliable scientific data for the classification of causes that lead to explantation.
“IOL explantation is an infrequent but serious event that deserves attention. Knowing the causes of explantation is epidemiologically important because they might reflect inadequate surgical practices, inadequate materials or design. From knowing the causes, we get important insights on how to improve manufacturing, selection and implantation techniques,” Jorge L. Alió, MD, PhD, said.
About 8 years
Author: Healio ophthalmology
Elderly man presents with acute-onset nonprogressive blurred vision in right eye
A 79-year-old man presented to Tufts New England Eye Center with a 6-week history of acute-onset nonprogressive blurred vision and reduced color vision in the right eye. The patient’s complete ocular and systemic review of systems was otherwise negative, including headache, weight loss, fevers or night sweats.
The patient’s medical history was notable for a remote history of prostate cancer that had been treated with radioactive seed implant in 1998. He had been recently hospitalized for renal failure of unclear etiology. His other medical conditions included insulin-dependent
$name
Full Story →
Adverum, Editas extend research collaboration
Adverum Biotechnologies and Editas Medicine have extended their collaboration agreement to explore the delivery of genome editing medicines to treat inherited retinal diseases, Adverum announced in a press release.
The companies are extending the research period through the third quarter of 2018, and Editas has a series of options exercisable between now and August 2020, the release said.
The collaboration focuses on utilizing Adverum’s adeno-associated viral vectors to deliver Editas’ CRISPR-based genome editing technologies in order to develop therapies for eye diseases, according
What qualifies as a stock market ‘plunge’?
I recently heard a financial reporter refer to a 100-point drop in the Dow Jones Industrial Average as “a 100-point plunge,” which made me laugh.
But then I thought, “What if the average investors were thinking the same thing, especially those older clients who were invested in the markets when 100 points was indeed a ‘plummet’ or plunge?” So, I decided to make some 2018 sense out of effect of market point movement to better put those into perspective.
To do that, and as a reference comparison, I think we (Read more...)
Mundipharma expands Santen partnership
Mundipharma has expanded a partnership with Santen Pharmaceutical, according to a press release.
The extension of an existing license for Saflutan (tafluprost) will add approximately 50 Middle Eastern and African markets.
In addition, the company will add Taptiqom (tafluprost/timolol) to its license in Canada, Australia, New Zealand, Latin America, the Middle East and Africa.
“We are delighted to further expand our ophthalmic portfolio as well as our successful partnership with Santen, ” Raman Singh, Mundipharma’s CEO, said in the release. “The extended licensing
Boston type 1 keratoprosthesis provides long-term visual acuity improvement
The Boston type 1 keratoprosthesis provided significant visual improvement in many eyes over the long term, according to a study.
The retrospective chart review of KPro implantations completed by a single surgeon at the Stein Eye Institute between May 1, 2004, and May 1, 2011, aimed to evaluate the long-term outcomes, complications and retention of the procedure. Patients’ preoperative ocular history, intraoperative data, and postoperative management and outcomes, including interval-corrected distance visual acuity (CDVA), were analyzed.
There were 74 KPros implanted in 58 eyes during
VIDEO: OSN/Wills Eye survey shows reputation matters
WAILEA, Hawaii — At Hawaiian Eye 2018, Carl D. Regillo, MD, discusses lessons learned from the recent survey sent to ophthalmologists in a joint effort by Ocular Surgery News and Wills Eye Hospital.
VIDEO: Patient selection key in EDOF and multifocal IOLs in post-LASIK patients
WAILEA, Hawaii — At Hawaiian Eye 2018, Eric D. Donnenfeld, MD, discusses pearls for cataract surgery using extended depth of focus and multifocal IOLs in patients who have had LASIK previously.
VIDEO: Lindstrom discusses Corboy Award, Hawaiian Eye Foundation
WAILEA, Hawaii — At Hawaiian Eye 2018, Richard L. Lindstrom, MD, discusses being awarded the Philip M. Corboy Award and the work of the Hawaiian Eye Foundation. To find out more about the Hawaiian Eye Foundation or to get involved, visit http://hawaiianeyefoundation.org/.
VIDEO: New EDOF lens shows advantages in early trials
WAILEA, Hawaii — At Hawaiian Eye 2018, John A. Hovanesian, MD, discusses early results implanting the SC9 extended depth of focus IOL (Cord) for presbyopia correction in cataract surgery.
Less surgically induced astigmatism seen with MICS
Patients with age-related cataracts who underwent microincision cataract surgery had less short-term and long-term surgically induced astigmatism compared with patients who underwent standard-incision cataract surgery.Researchers conducted a meta-analy…
VIDEO: New Ocular Therapeutix CEO highlights opportunities for 2018
WAILEA, Hawaii — At Hawaiian Eye 2018, Antony Mattessich, president and CEO of Ocular Therapeutix, discusses the company’s plans moving forward into 2018.
First Prima bionic vision system successfully implanted in human
The first Prima bionic vision system has been successfully implanted and activated in a human subject, according to a press release from Pixium Vision.
The system, a miniature wireless photovoltaic subretinal implant, elicited visual perception in a patient with severe vision loss due to atrophic dry age-related macular degeneration. The patient will now begin a re-education phase as indicated by the trial protocol, the release said.
“Following activation, the patient reported a first perception of light from the central zone where there was none previously,” Yannick Le Mer, MD, the
VIDEO: Awareness needed of anterior segment concerns in cataract surgery in diabetic patients
WAILEA, Hawaii —At Hawaiian Eye 2018, Kendall E. Donaldson, MD, MS, discusses special concerns surgeons should be aware of in the anterior segment when performing cataract surgery in patients with diabetes. The majority of the discussion around cataract surgery in patients with diabetes normally involves the posterior segment, but there are important considerations for the anterior segment as well.
Nearly half of physicians experience burnout
In the United States, 42% of physicians report burnout and many also report depression, according to Medscape’s 2018 National Physician Burnout and Depression Report.
Medscape conducted an online survey to determine the prevalence and effect of burnout and depression among physicians in the United States. A total of 15,543 practicing physicians across 29 specialties completed the survey.
Data from the survey revealed that 42% of physicians experienced burnout, 15% experienced depression —colloquially (12%) or clinically (3%) — and 14% experienced both burnout and depression.
Novartis, Spark enter licensing agreement for Luxturna outside US
Novartis and Spark Therapeutics have entered a licensing agreement, with Novartis obtaining the rights to develop, register and commercialize Luxturna outside of the United States, according to a press release.Luxturna (voretigene neparvovec-rzyl) is t…
Ocular Therapeutix announces public stock offering
Ocular Therapeutix announced an underwritten public offering of 6.5 million shares of its common stock, priced at $5 per share, according to a press release.The underwriter of the offering will be granted a 30-day option to purchase up to an additional…
HHS civil rights division under debate of ‘conflicting moral obligations’
The Trump administration announced a new civil rights division within the Department of Health and Human Services that proposes to protect health care workers who refuse to render services that fall outside their religious or moral beliefs.
“Laws protecting religious freedom and conscience rights are just empty words on paper if they aren’t enforced,” Roger Severino, director of the Office for Civil Rights, said in a release announcing the establishment of the Conscience and Religious Freedom Division. “No one should be forced to choose between helping sick people and
Phase 3 trial of Apellis’ geographic atrophy treatment to begin this year
Apellis Pharmaceuticals finalized plans for a phase 3 clinical trial program for APL-2, its treatment for geographic atrophy associated with age-related macular degeneration, the company announced in a press release.The program, set to begin in the sec…